v3.25.4
Note 1 - Description of the Business, Basis of Presentation and Summary of Significant Accounting Policies (Tables)
9 Months Ended
Dec. 31, 2025
Notes Tables  
Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block]
  

December 31,

 
  

2025

  

2024

 
         

Equity based warrants to purchase common shares

  4,334   87,531 

Convertible Notes - common shares (1)

  -   33,250 

Bridge Financing Warrants

  25,003   25,003 

Stock options granted under Company's incentive plan

  13,500   235,983 

Series A warrants

  55,500   1,533,096 

Series B warrants

  1,477,596   - 

Representative warrants

  180,641   91,985 

Series C warrants

  9,003,332   - 
         

Total potentially dilutive securities

  10,759,906   2,006,848 
         

(1) Shares for the convertible note proceeds received